247 related articles for article (PubMed ID: 9988795)
1. Telomerase activity in complete hydatidiform mole.
Bae SN; Kim SJ
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
[TBL] [Abstract][Full Text] [Related]
2. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles.
Amezcua CA; Bahador A; Naidu YM; Felix JC
Am J Obstet Gynecol; 2001 Jun; 184(7):1441-6. PubMed ID: 11408866
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in gestational trophoblastic disease.
Cheung AN; Zhang DK; Liu Y; Ngan HY; Shen DH; Tsao SW
J Clin Pathol; 1999 Aug; 52(8):588-92. PubMed ID: 10645228
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in complete hydatidiform mole.
Sukcharoen N; Mutirangura A; Limpongsanurak S
J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
[TBL] [Abstract][Full Text] [Related]
5. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J
Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behavior.
Bolis G; Belloni C; Bonazzi C; Mangili G; Presti M; Zanaboni F; Mangioni C
Tumori; 1988 Feb; 74(1):93-6. PubMed ID: 2451334
[TBL] [Abstract][Full Text] [Related]
7. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity and the subunit of telomerase in hydatidiform mole and their relationship with the development of postmolar tumor.
Wang F; Huang H; Kang X; Chen B; Li Y
Eur J Gynaecol Oncol; 2006; 27(5):473-6. PubMed ID: 17139981
[TBL] [Abstract][Full Text] [Related]
9. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
10. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
12. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
13. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor.
Lage JM; Berkowitz RS; Rice LW; Goldstein DP; Bernstein MR; Weinberg DS
Obstet Gynecol; 1991 Jan; 77(1):111-5. PubMed ID: 1845777
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles.
Shi Z; Zhang T; Long W; Wang X; Zhang X; Ling X; Ding H
Int J Gynecol Cancer; 2012 Sep; 22(7):1125-9. PubMed ID: 22801034
[TBL] [Abstract][Full Text] [Related]
16. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
17. Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole.
Nishi H; Ohyashiki K; Fujito A; Yahata N; Ohyashiki JH; Isaka K; Takayama M
Placenta; 1999 May; 20(4):317-23. PubMed ID: 10329353
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions.
Montes M; Roberts D; Berkowitz RS; Genest DR
Am J Clin Pathol; 1996 Apr; 105(4):411-6. PubMed ID: 8604683
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies.
Chen RJ; Chu CT; Huang SC; Chow SN; Hsieh CY
Hum Reprod; 2002 Feb; 17(2):463-8. PubMed ID: 11821296
[TBL] [Abstract][Full Text] [Related]
20. Hydatidiform moles.
Heath JM; Bu TH; Brereton WF
Am Fam Physician; 1985 May; 31(5):123-31. PubMed ID: 2581433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
